E. Bruni

Type de document

Co-auteur

S. Trabanelli

V. Salvestrini

B. Salomé

D. Mavilio

E. Marcenaro

A. Gomez-Cadena

D. Gfeller

A. Curti

T. Wyss

G. Verdeil

G. Vanoni

D. Vanhecke

C. Tresoldi

A. Tozzo

P. Tentorio

D. Taurino

M. Suffiotti

A. Steinle

O. Spinelli

A. Schulz

A. Santoro

S. Salvatore

D.F. Ruan

M. Rossi

P. Romero

C. Riether

A. Rambaldi

J. Racle

I. Pizzitola

P.G. Pelicci

C. Papayannidis

R. Pallavi

A. Ochsenbein

H. Morita

S. Minucci

K. Michaud

ANJ McKenzie

L. Mazzarella

A. Martinez Usatorre

R. Loyon

E.O. Leibundgut

M. Lecciso

P. Jandus

C. Jandus

E.M. Jacobsen

A Horowitz

M. Hoenig

P.C. Ho

C. Grandclement

M. Girotra

E. Giarin

P. Falvo

M.G. Della Porta

G. Coukos

C. Conrad

F. Ciceri

M.F. Chevalier

C. Carlo-Stella

P. Bohner

G. Basso

G.M. Baerlocher

C.A. Akdis

Date

Source

Serveur académique Lausannois (2)

Mot-clé

cytotoxicité (2) survie (2) Survival (2) Human beings (2) Growth (2) Cells (2) Growth (2) tumeur (1) thérapie (1) spectacle (1) modèle (1) marqueur (1) leucémie (1) immunité (1) allergie (1) famille (1) ligne (1) cancer (1) taux (1) Diagnosis (1) Treatment (1) Cancer (1) Diseases (1) Observations (1) Observations (1) Phenotype (1) Acute myeloid leukemia (1) Tretinoin (1) Tissues (1) Therapeutics (1)

Documents écrit par E. Bruni (2) | parle de E. Bruni (0)

CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML.

B. Salomé et al. (26 nov. 2019)

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.

S. Trabanelli et al. (19 sept. 2017)